These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17057057)

  • 1. Changes in reimbursement rates and rules associated with the Medicare Prescription Drug Improvement and Modernization Act. Introduction.
    Johnson PE
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S2-6. PubMed ID: 17057057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding basic concepts and strategies for obtaining pharmaceutical reimbursement.
    Jarrett AT
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S7-9. PubMed ID: 17057059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Medicare Prescription Drug Improvement and Modernization Act on the bottom line.
    Jarrett AT
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S10-3. PubMed ID: 17057054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical reimbursement: an overview.
    Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S4-10. PubMed ID: 18192246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implications of the Medicare Modernization Act for dual eligibles.
    Deshpande M
    Am J Geriatr Cardiol; 2005; 14(6):298-300. PubMed ID: 16276126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the design of competitive bidding in Medicare Advantage.
    Cawley JH; Whitford AB
    J Health Polit Policy Law; 2007 Apr; 32(2):317-47. PubMed ID: 17463410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Medicare Part D drug benefit: lessons from the experience with drug discount cards.
    Doering PL
    Am J Geriatr Cardiol; 2005; 14(6):308-12. PubMed ID: 16276128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One pill, many prices: variation in prescription drug prices in selected government programs.
    Gencarelli DM
    Issue Brief George Wash Univ Natl Health Policy Forum; 2005 Aug; (807):1-20. PubMed ID: 16167399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part I--Medicare prescription drug coverage (Part D): the promise.
    Witten B
    Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
    [No Abstract]   [Full Text] [Related]  

  • 13. What does the Medicare prescription drug legislation mean for the American cardiologist?
    Schwartz JB; Redberg RF
    Am J Geriatr Cardiol; 2005; 14(6):317-24. PubMed ID: 16276130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helping Medicare patients benefit from the new Medicare drug benefit: an overview with practice tips.
    Donohue J; Hanlon JT
    Am J Geriatr Cardiol; 2005; 14(6):291-7. PubMed ID: 16276125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in federal reimbursement for home health-care services and products.
    Curtiss FR
    Am J Hosp Pharm; 1988 Aug; 45(8):1682-90. PubMed ID: 3064589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Medicare Prescription Drug Improvement and Modernization Act: prescription drugs and academic medicine.
    Frencher SK; Glied S
    Acad Med; 2006 Sep; 81(9):812-6. PubMed ID: 16936488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
    Academy of Managed Care Pharmacy
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare Part D: an overview of its practical and clinical impact.
    Usdin S
    Am J Geriatr Cardiol; 2005; 14(6):284-8; quiz 289-90. PubMed ID: 16276124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Medicare Prescription Drug Improvement and Modernization Act on the management of colorectal cancer.
    Siegel J
    Am J Health Syst Pharm; 2006 May; 63(9 Suppl 2):S18-21. PubMed ID: 16641253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Emmer S; Allendorf L
    J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.